Driving Ability Evaluation System to Improve the Conditional Driving License System: Feasibility Study of High-risk Drivers.
1 other identifier
interventional
100
1 country
1
Brief Summary
The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities of elderly drivers. This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Therefore, this study aims to measure the physical driving function, general physical function and cognitive function of elderly drivers. to identify the correlation between their outcomes and the VR driving simulator's result
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2024
CompletedFirst Posted
Study publicly available on registry
March 4, 2024
CompletedStudy Start
First participant enrolled
March 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 4, 2024
February 1, 2024
10 months
February 14, 2024
February 25, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility of VR driving simulator
A questionnaire evaluating symptoms of simulator sickness such as dizziness or nausea and comprehension of contents
2 hours
Driving performance in simulator, measured by driving errors
Driving performance in simulator will be measured by driving errors during VR simluation of driving. These errors will be evaluated based on the criteria used for driving license tests, including violations of traffic laws.
15 minutes
Study Arms (1)
Elderly drivers
OTHERIndividuals over the age of 65 who are currently driving
Interventions
Evaluation of usual road driving abilities and assessment of response capabilities in accident-prone situations through a VR driving simulator
Evaluation of cognitive levels including attention and memory (the Trail Making Test, Digit Span Test, Auditory (or Visual) Continuous Performance Test , and Card Sorting)
Conducting qualified tests of a person's basic physical driving ability including steering, acceleration and braking, using Driver Test Station(Autoadapt AB, Stenkullen, Sweden)
Evaluation of functional capability and provide a measure of the biological age of an older individual by measuring lower extremity physical performance status(standing balance, walking speed, and chair stand tests).
Researchers and driver's license supervisors ride in the driver's license test vehicle to evaluate the subject's actual driving ability. the validity of the VR simulator by comparing the results of the VR simulator with the actual vehicle driving ability.
Eligibility Criteria
You may qualify if:
- Individuals over the age of 65 who are currently driving.
- Individuals capable of understanding and following the researcher's instructions.
- Individuals who can understand the purpose of the research and have consented to participate
You may not qualify if:
- Those who have not signed the consent form.
- Individuals with a history of severe dizziness or epilepsy.
- Patients with restrictions on sitting in a wheelchair or chair for more than 30 minutes.
- Patients with severe shoulder pain.
- Patients whose range of motion in major joints is restricted by more than 50%.
- Pregnant women.
- Patients with pressure sores.
- Patients with limitations on simulator use due to heterotopic ossification.
- Patients with acute fractures.
- Other patients for whom participation in the study is expected difficult.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate clinical professor
Study Record Dates
First Submitted
February 14, 2024
First Posted
March 4, 2024
Study Start
March 15, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
March 4, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share